|
Tissue-Specific Mechanisms of Regulatory T Cells in the CNS during Autoimmune Encephalomyelitis |
1R01AI168063-01 |
|
NIAID |
2022 |
|
Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course |
1R01AI169070-01A1 |
|
NIAID |
2022 |
|
Metabolic regulators of Treg/Th17 balance in CNS autoimmunity |
1R01AI169075-01A1 |
|
NIAID |
2022 |
|
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots |
1R01AI169686-01 |
|
NIAID |
2022 |
|
Defining how TCR strength of signal modulates Treg function |
1R01AI169835-01A1 |
|
NIAID |
2022 |
|
Novel mouse models to dissect the role of genetics, sex, and environment in heterogeneous outcomes in CNS autoimmune disease |
1R01AI172166-01 |
|
NIAID |
2022 |
|
Regulation of the Microglial Neuroimmune Response by Long Non-Coding RNAs |
1R15AI156879-01A1 |
|
NIAID |
2022 |
|
Alu dsRNAs as adjuvants for influenza vaccines |
1R21AI164107-01A1 |
|
NIAID |
2022 |
|
Identification of cellular heme transport receptors that regulate T cell function |
1R21AI164722-01A1 |
|
NIAID |
2022 |
|
Combating chronic neuroinflammatory disorders by targeting NAC1 |
1R21AI167793-01A1 |
|
NIAID |
2022 |